Healthcare Triangle Inc
HCTI.OQ- Latest Trade
- trading higher0.35USD
- 0.04
- 13.57%
- As of Jan 29 2023. Values delayed up to 15 minutes
- Day Range
- 0.28 - 0.35
- 52-Week Range
- 0.11 - 1.61
- Previous Close
- 0.31
- Open
- 0.30
- Volume
- 114,053.00
- 3 Month Average Trading Volume
- 49.44
- Shares Out (Mil)
- 41.63
- Market Cap
- 14.53
- Forward P/E
- -99,999.99
- Dividend Yield
- 0.00
Key Statistics
mean rating - analysts
- P/E Excl. Extra Items (TTM)
- 0.00
- Price To Sales (TTM)
- 0.33
- Price To Book (Quarterly)
- 0.78
- Price To Cash Flow (Per Share TTM)
- 0.00
- Total Debt/Total Equity (Quarterly)
- 13.96
- Long Term Debt/Equity (Quarterly)
- 0.00
- Return On Investment (TTM)
- -72.79
- Return On Equity (TTM)
- -45.20
2021 (millions USD)
About Healthcare Triangle Inc (HCTI.OQ)
Company Information
Healthcare Triangle, Inc. is a healthcare information technology company, which is focused on advancing , industry-transforming solutions in the areas of cloud services, data science, professional and managed services for the healthcare and life sciences industry. The Company supports healthcare delivery organizations, healthcare insurance companies, pharmaceutical, and life sciences, biotech companies, and medical device manufacturers in their efforts to improve data management, develop analytical insights into their operations, and deliver measurable clinical, financial, and operational improvements. It offers a comprehensive suite of software, solutions, platforms and services that enables some of healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to real-world evidence, and accelerate their digital transformation.
Address
4309 Hacienda Dr., Suite 150PLEASANTON, CA
945888
United States
Industry
Software & Programming
Executive Leadership
- Thyagarajan Ramachandran
- Chief Financial Officer
- Anand Kumar
- Senior Vice President - Sales
- Michael Gill
- Vice President - Finance
- Lakshmanan Kannappan
- Head of Strategic Partnerships, Director
- Shibu Kizhakevilayil
- Head of M&A, Director
- Sanjay Dalwani
- Chief Revenue Officer
- David A. Rosa
- Independent Director
Financials
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,927.40 | 0.10% |
| Copper | 783.30 | 1.20% |
| Brent Crude Oil | 87.45 | 0.91% |
| CBOT Soybeans | 1,509.50 | -- |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,070.56 | 0.25% |
| Euro STOXX 50 | 4,178.01 | 0.10% |
| FTSE 100 | 7,765.15 | 0.05% |
| Nikkei 225 | 27,382.56 | -- |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes